No Data
No Data
Canaccord Genuity Remains a Buy on Jamieson Wellness Inc (JWEL)
BMO Capital Sticks to Their Buy Rating for Jamieson Wellness Inc (JWEL)
Jamieson Wellness Brief: Keeps Outperform But Target Edged Up To C$36.50 From $36 at National Bank On Q2 "In Line", Annual Guidance Reiterated But Below Street Expectations
Jamieson Wellness Brief: Maintaining Outlook for Fiscal 2024 and 2025
Jamieson Wellness Brief: Q2 Diluted Earnings per Share Was $0.20; Adjusted Diluted Earnings per Share Was $0.35
Jamieson Wellness Inc. Announces Date of Second Quarter 2024 Financial Results and Conference Call